Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2026-04-15 @ 7:34 PM
Study NCT ID:
NCT04704661
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2021-01-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-01
First Submit QC Date:
None
Study First Post Date:
2021-01-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED